Susquehanna International Group’s OptimizeRx OPRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$193K Sell
30,800
-2,100
-6% -$19.5K ﹤0.01% 11743
2025
Q4
$403K Sell
32,900
-10,800
-25% -$176K ﹤0.01% 9280
2025
Q3
$896K Sell
43,700
-4,700
-10% -$74.6K ﹤0.01% 7599
2025
Q2
$653K Buy
48,400
+30,800
+175% +$337K ﹤0.01% 8541
2025
Q1
$152K Buy
+17,600
New +$108K ﹤0.01% 11218
2024
Q3
Sell
-58,000
Closed -$580K 12739
2024
Q2
$580K Buy
+58,000
New +$637K ﹤0.01% 7900
2024
Q1
Sell
-15,300
Closed -$219K 13006
2023
Q4
$219K Buy
+15,300
New +$147K ﹤0.01% 10487
2023
Q3
Sell
-160,800
Closed -$2.3M 12685
2023
Q2
$2.3M Sell
160,800
-1,900
-1% -$27.1K ﹤0.01% 4869
2023
Q1
$2.38M Sell
162,700
-56,600
-26% -$947K ﹤0.01% 4788
2022
Q4
$3.68M Buy
219,300
+51,400
+31% +$889K ﹤0.01% 3695
2022
Q3
$2.49M Buy
167,900
+12,300
+8% +$243K ﹤0.01% 4472
2022
Q2
$4.26M Buy
155,600
+136,900
+732% +$4.06M ﹤0.01% 3443
2022
Q1
$705K Sell
18,700
-232,100
-93% -$10.3M ﹤0.01% 8063
2021
Q4
$15.6M Sell
250,800
-3,200
-1% -$242K ﹤0.01% 2126
2021
Q3
$21.7M Buy
254,000
+19,000
+8% +$1.19M ﹤0.01% 1889
2021
Q2
$14.5M Sell
235,000
-28,800
-11% -$1.47M ﹤0.01% 2406
2021
Q1
$12.9M Buy
263,800
+213,400
+423% +$10.3M ﹤0.01% 2411
2020
Q4
$1.57M Buy
50,400
+5,200
+12% +$127K ﹤0.01% 5629
2020
Q3
$942K Buy
+45,200
New +$776K ﹤0.01% 6258
2019
Q4
Sell
-17,200
Closed -$249K 10373
2019
Q3
$249K Buy
+17,200
New +$266K ﹤0.01% 8684

Other funds holding OPRX

Susquehanna International Group's OPRX Position: Q1 2026 in Review

Susquehanna International Group reduced its OptimizeRx (OPRX) stake by 62% in Q1 2026, selling an estimated $171K and leaving 11,373 shares worth $71.4K. The position accounts for ﹤0.01% of the portfolio, ranked #12500.

Susquehanna International Group first reported a position in OPRX in Q4 2018 and has held it in 16 quarters since. The position peaked at $2.95M in Q1 2023. 127 funds tracked by Wall St. Rank hold OPRX as of Q1 2026.

  • Susquehanna International Group held 11,373 shares of OptimizeRx worth $71.4K as of Q1 2026.
  • Susquehanna International Group sold 18,368 OptimizeRx shares in Q1 2026, an estimated $171K.
  • OptimizeRx made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #12500 holding.
  • Susquehanna International Group first reported a position in OptimizeRx in Q4 2018 and has held it in 16 quarters since.
  • Susquehanna International Group's OptimizeRx position peaked at $2.95M in Q1 2023.
  • 127 funds tracked by Wall St. Rank held OptimizeRx as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.